Invesco’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $354K | Sell |
132,218
-486
| -0.4% | -$1.3K | ﹤0.01% | 3306 |
|
2025
Q1 | $187K | Buy |
132,704
+98,335
| +286% | +$139K | ﹤0.01% | 3512 |
|
2024
Q4 | $68.4K | Buy |
34,369
+1,700
| +5% | +$3.38K | ﹤0.01% | 3651 |
|
2024
Q3 | $103K | Sell |
32,669
-290
| -0.9% | -$913 | ﹤0.01% | 3602 |
|
2024
Q2 | $104K | Buy |
+32,959
| New | +$104K | ﹤0.01% | 3731 |
|
2022
Q1 | – | Sell |
-242,643
| Closed | -$4.9M | – | 3963 |
|
2021
Q4 | $4.9M | Buy |
242,643
+19,045
| +9% | +$385K | ﹤0.01% | 2412 |
|
2021
Q3 | $6.07M | Sell |
223,598
-2,110
| -0.9% | -$57.3K | ﹤0.01% | 2278 |
|
2021
Q2 | $5.5M | Sell |
225,708
-8,146
| -3% | -$198K | ﹤0.01% | 2383 |
|
2021
Q1 | $5.71M | Buy |
233,854
+3,692
| +2% | +$90.1K | ﹤0.01% | 2308 |
|
2020
Q4 | $7.37M | Buy |
230,162
+70,386
| +44% | +$2.25M | ﹤0.01% | 1963 |
|
2020
Q3 | $5.27M | Buy |
+159,776
| New | +$5.27M | ﹤0.01% | 1979 |
|